MetaCap

Cadrenal Therapeutics Earnings

NASDAQ: CVKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9101-0.0195 (-2.10%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Mon, Nov 9, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.91

Cadrenal Therapeutics earnings summary

Cadrenal Therapeutics is scheduled to report Sep/2026 earnings on Nov 9, 2026, with analysts expecting EPS of $-0.91.

Summary generated from market data by MetaCap's automated system. Methodology

Related